Literature DB >> 9627697

The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin.

T N Dam1, B Møller, J Hindkjaer, K Kragballe.   

Abstract

Local activation of T lymphocytes appears to play an important role in psoriasis and autoimmune skin disease. 1 alpha,25-dihydroxyvitamin D3 and the vitamin D3 analog calcipotriol have been shown to inhibit immune induction in vitro. The purpose of the present study was to investigate the in vivo effect of calcipotriol on Langerhans cells in normal human skin and to determine the effect of 1,25-dihydroxyvitamin D3 and calcipotriol on isolated Langerhans cells to induce autologous T-cell proliferation. Using confocal laser scanning microscopy of epidermal suction blister roofs, it was found that application of calcipotriol cream to normal human skin for 4 d resulted in a dose-dependent decrease in the number of CD1a+ cells with a dendritic morphology and in the number of dendrites per cell. The suppressive effect of calcipotriol on Langerhans cells was as strong as that of the potent corticosteroid mometasonfuroate. In Langerhans cell-enriched cell suspensions (60-97% pure) isolated from normal human skin, 1,25-dihydroxyvitamin D3 and calcipotriol (10(-8)-10(-7) M) significantly suppressed their ability to stimulate antigen-dependent T-cell proliferation. Furthermore, the vitamin D receptor was detected by Western blot analysis in the isolated Langerhans cells. Neither immunohistochemical studies nor flow cytometry of Langerhans cells showed any change in the human leukocyte antigen-DR expression after 48 h culture with antigen with or without calcipotriol. It is proposed that the inhibitory effects of the vitamin D3 on Langerhans cells may induce immunosuppression in the skin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9627697

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  17 in total

Review 1.  Psoriasis in children: a guide to its diagnosis and management.

Authors:  J Leman; D Burden
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Vitamin D metabolism and innate immunity.

Authors:  Venu Lagishetty; Nancy Q Liu; Martin Hewison
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

3.  Self-control study of combination treatment of 308 nm excimer laser and calcipotriene ointment on stable psoriasis vulgaris.

Authors:  Ya-Juan Tang; Wan-Wen Xu; Xiao-Ming Liu; Ru-Zhi Zhang; Chun-Xing Xu; Bin Xu; Sai Cheng; Qi Liu
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 4.  Vitamin D and the intracrinology of innate immunity.

Authors:  Martin Hewison
Journal:  Mol Cell Endocrinol       Date:  2010-02-13       Impact factor: 4.102

Review 5.  Vitamin D and the immune system: new perspectives on an old theme.

Authors:  Martin Hewison
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

Review 6.  Vitamin D3: a helpful immuno-modulator.

Authors:  Michelino Di Rosa; Michele Malaguarnera; Ferdinando Nicoletti; Lucia Malaguarnera
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

7.  Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol.

Authors:  Mehran Ghoreishi; Paxton Bach; Jennifer Obst; Mitsuhiro Komba; James C Fleet; Jan P Dutz
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

Review 8.  Novel aspects of corneal angiogenic and lymphangiogenic privilege.

Authors:  David Ellenberg; Dimitri T Azar; Joelle A Hallak; Faisal Tobaigy; Kyu Yeon Han; Sandeep Jain; Zhongjun Zhou; Jin-Hong Chang
Journal:  Prog Retin Eye Res       Date:  2010-01-25       Impact factor: 21.198

Review 9.  Harnessing dendritic cells in inflammatory skin diseases.

Authors:  Chung-Ching Chu; Paola Di Meglio; Frank O Nestle
Journal:  Semin Immunol       Date:  2011-02-04       Impact factor: 11.130

Review 10.  The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression.

Authors:  Asurayya Worrede; Stephen M Douglass; Ashani T Weeraratna
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.